Financial News
Arcellx, Inc. - Common Stock (NQ: ACLX )
62.12
-0.44
(-0.70%)
Streaming Delayed Price
Updated: 12:03 PM EDT, Jul 22, 2024
Add to My Watchlist
Headline News about Arcellx, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Decoding 8 Analyst Evaluations For Arcellx
Today 10:00 EDT
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings For Arcellx
June 18, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Expert Ratings For Arcellx
May 31, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations For Arcellx's Future
May 14, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Peering Into Arcellx's Recent Short Interest
April 15, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/02/29/image11.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Ozempic-weight-loss-pill_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Where Arcellx Stands With Analysts
December 11, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](/next-assets/images/schema-image-default.png)
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/12/johnson_controls_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/11/aclx.png?width=1200&height=800&fit=crop)
![](https://barchart-news-media-prod.aws.barchart.com/EXCLSV/0d02574e629de465e51306de4d4fd70c/0kmuvalregzrx8go.png)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://www.investors.com/wp-content/uploads/2023/11/IT04-Arcellx-01-news.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/02/aclx.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/02/image39.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/02/starbucks_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/02/cancer.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.